3 recruiting, 2 not yet recruiting. 3 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Not yet recruiting 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Pan Xiangbin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Intensive Statin Therapy for Neuroprotection in TAVR（PISTNT） Intensive statin treatment, Placebo Control - Aortic Stenosis, Cerebral Ischaemic Injury | Phase 4 | Not yet recruiting | Pan Xiangbin | 500 | 2025-10-01 | 2025-07-28 |
| Echocardiography Guided TAVR (Echo TAVR) Transcatheter Aortic Valve Replacemen, Echocardiography | Recruiting | Pan Xiangbin | 20 | 2025-02-18 | 2025-06-19 | |
| Comparison of Transcatheter Edge-to-edge Repair Using Echo Only with Echo Combined with X Ray for Mitral Regurgitation (ECHO-CLIP) Echocardiographic guidance, Fluoroscopic guidance - Mitral Regurgitation | Not applicable | Recruiting | Pan Xiangbin | 200 | 2024-03-29 | 2024-11-12 |
| A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis Transcatheter aortic valve replacement - Severe Aortic Stenosis | Not applicable | Recruiting | Pan Xiangbin | 120 | 2023-10-18 | 2023-11-18 |
| To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment Transfemoral mitral-valve repair - Mitral Valve Insufficiency | Not applicable | Not yet recruiting | Pan Xiangbin | 140 | 2022-08-30 | 2022-08-19 |
Aortic Valve Stenosis (2) · Mitral Valve Insufficiency (2) · Cardiovascular Diseases (1) · Heart Valve Diseases (1)
Transcatheter Aortic Valve Replacement (1)
China (4)
Xiangbin Pan (1) · Xiangbin Pan, MD (1)